Clinical Trial Update: Compare the Efficacy of Mepilex and Keramatrix in Second Degree Burn Wounds [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial comparing Mepilex and Keramatrix for second-degree burn wounds has been withdrawn (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Second-degree Burns

Drugs mentioned

• Keramatrix
• Mepilex

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Skin Burn Degree Second | Phase 2, Phase 3 | Status: WITHDRAWN